INFLIXIMAB
infliximab 120 mg/mL injection, 1 mL pen device
INFLIXIMAB (13076F)
13076F
Manner of administration:Injection
Restriction 17431
Indication: Severe chronic plaque psoriasis
Treatment phase: Continuing treatment (whole body, or, face/hand/foot) with subcutaneous form or switching
from intravenous form to subcutaneous form
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 2 | # of repeats: 5 | DPMQ: $578.68 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Remsima SC | |||||